BioMarin Pharmaceuticals Inc
Symbol: BMRN (NASDAQ)
56.09
▲ (2.24%) 1.231
Company Description:
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
Key Stats
- Today's Open: $54.646
- Today's High: $56.624
- Today's Low: $54.646
- Today's Volume: 1
- Yesterday Close: $54.86
- Yesterday High: $55.75
- Yesterday Low: $54.26
- Yesterday Volume: 2.95M
- Last Min Volume: 0
- Last Min High: $56.093
- Last Min Low: $56.091
- Last Min VWAP: $0
Company Profile
- Name: BioMarin Pharmaceuticals Inc
- Website: https://www.biomarin.com
- Listed Date: 1999-07-23
- Location: NOVATO, CA
- Market Status: Active
- CIK Number: 0001048477
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $10.53B
- Round Lot: 100
- Outstanding Shares: 192.01M
- Asset Type: CS
RECENT FILINGS FOR BMRN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-11 | 8-K | View |
| 2025-08-05 | 4 | View |
| 2025-08-05 | 3 | View |
| 2025-08-05 | S-8 | View |
| 2025-08-05 | 10-Q | View |
| 2025-08-04 | 8-K | View |
| 2025-08-01 | 8-K | View |
| 2025-07-01 | SC TO-T/A | View |
| 2025-06-17 | SC TO-T/A | View |
| 2025-06-13 | CORRESP | View |
| 2025-06-13 | SC TO-T/A | View |
| 2025-06-04 | SC TO-T/A | View |
| 2025-06-02 | SC TO-T | View |
| 2025-05-22 | 4 | View |
| 2025-05-22 | 4 | View |
| 2025-05-22 | 4 | View |
| 2025-05-22 | 4 | View |
| 2025-05-22 | 4 | View |
Latest News on BMRN